# Squadron Capital Management LLC 13F Q2 2026: $322 million

Squadron Capital Management LLC reported $322 million in 13F securities across 43 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Relmada Therapeutics Inc at $50.9 million, 15.8% of the reported value. Since Q1 2026 it opened 24 new positions and exited 18.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $322,245,820
- Positions: 43
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 2050709
- Form 13F file number: 028-26573
- CRD number: 334296
- Business address: 1211 West 22nd Street Suite 1008, Oak Brook, IL 60523
- SEC filing: [0002050709-26-000027](https://www.sec.gov/Archives/edgar/data/2050709/000205070926000027/0002050709-26-000027-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/squadron-capital-management-llc-334296)

## Top 25 holdings by value

The largest of 43 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Relmada Therapeutics Inc](https://specstream.ai/data/institutional-holders/relmada-therapeutics-inc-75955j402) | COM | 7,350,000 | $50.9 million | -1,124,571 |
| [C4 Therapeutics Inc](https://specstream.ai/data/institutional-holders/c4-therapeutics-inc-12529r107) | COM STK | 7,200,000 | $33.6 million | +4,950,000 |
| [Cogent Biosciences Inc](https://specstream.ai/data/institutional-holders/cogent-biosciences-inc-19240q201) | COM | 865,000 | $33.5 million | +77,508 |
| [Kodiak Sciences Inc](https://specstream.ai/data/institutional-holders/kodiak-sciences-inc-50015m109) | COM | 500,000 | $19.5 million | +120,000 |
| [Relay Therapeutics Inc](https://specstream.ai/data/institutional-holders/relay-therapeutics-inc-75943r102) | COM | 970,000 | $18.1 million | +297,500 |
| [Zentalis Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/zentalis-pharmaceuticals-inc-98943l107) | COM | 3,700,000 | $17.9 million | +69,000 |
| [Edgewise Therapeutics Inc](https://specstream.ai/data/institutional-holders/edgewise-therapeutics-inc-28036f105) | COM | 290,000 | $11.8 million | -60,000 |
| [Maze Therapeutics Inc](https://specstream.ai/data/institutional-holders/maze-therapeutics-inc-578784100) | COM | 335,000 | $10 million | +77,500 |
| [Inventiva SA](https://specstream.ai/data/institutional-holders/inventiva-sa-46124u107) | ADS | 2,435,000 | $9.2 million | +1,900,000 |
| [Adlai Nortye LTD](https://specstream.ai/data/institutional-holders/adlai-nortye-ltd-00704r109) | SPONSORED ADS | 764,876 | $8.8 million | -500,355 |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 160,000 | $8.1 million | New |
| Arrivent Biopharma Inc | COM (call) | 183,000 | $6.4 million | +73,000 |
| [Palisade Bio Inc](https://specstream.ai/data/institutional-holders/palisade-bio-inc-696389402) | COM | 3,000,000 | $6.3 million | No change |
| Bioage Labs Inc | COM (call) | 250,000 | $6.1 million | New |
| [Inhibikase Therapeutics Inc](https://specstream.ai/data/institutional-holders/inhibikase-therapeutics-inc-45719w205) | COM NEW | 3,000,000 | $6.1 million | -500,000 |
| [Adagene Inc](https://specstream.ai/data/institutional-holders/adagene-inc-005329107) | ADS | 1,250,000 | $5.3 million | New |
| [Forte Biosciences Inc](https://specstream.ai/data/institutional-holders/forte-biosciences-inc-34962g208) | COM NEW | 225,000 | $4.8 million | New |
| Rezolute Inc | COM NEW (call) | 900,000 | $4.7 million | New |
| [Inflarx NV](https://specstream.ai/data/institutional-holders/inflarx-nv-n44821101) | COM | 2,000,000 | $4.5 million | New |
| [Assembly Biosciences Inc](https://specstream.ai/data/institutional-holders/assembly-biosciences-inc-045396207) | COM NEW | 160,000 | $4.4 million | New |
| Compass Pathways PLC | SPONSORED ADS (call) | 305,000 | $4.3 million | New |
| [Promis Neurosciences Inc](https://specstream.ai/data/institutional-holders/promis-neurosciences-inc-74346m505) | COM SHS | 324,977 | $4.3 million | No change |
| [Contineum Therapeutics Inc](https://specstream.ai/data/institutional-holders/contineum-therapeutics-inc-21217b100) | CL A | 260,000 | $4.3 million | New |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 300,000 | $4.2 million | New |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 85,000 | $4 million | New |

## New positions in Q2 2026

24 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Enliven Therapeutics Inc](https://specstream.ai/data/institutional-holders/enliven-therapeutics-inc-29337e102) | COM | 160,000 | $8.1 million |
| Bioage Labs Inc | COM (call) | 250,000 | $6.1 million |
| [Adagene Inc](https://specstream.ai/data/institutional-holders/adagene-inc-005329107) | ADS | 1,250,000 | $5.3 million |
| [Forte Biosciences Inc](https://specstream.ai/data/institutional-holders/forte-biosciences-inc-34962g208) | COM NEW | 225,000 | $4.8 million |
| Rezolute Inc | COM NEW (call) | 900,000 | $4.7 million |
| [Inflarx NV](https://specstream.ai/data/institutional-holders/inflarx-nv-n44821101) | COM | 2,000,000 | $4.5 million |
| [Assembly Biosciences Inc](https://specstream.ai/data/institutional-holders/assembly-biosciences-inc-045396207) | COM NEW | 160,000 | $4.4 million |
| Compass Pathways PLC | SPONSORED ADS (call) | 305,000 | $4.3 million |
| [Contineum Therapeutics Inc](https://specstream.ai/data/institutional-holders/contineum-therapeutics-inc-21217b100) | CL A | 260,000 | $4.3 million |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 300,000 | $4.2 million |
| [Definium Therapeutics Inc](https://specstream.ai/data/institutional-holders/definium-therapeutics-inc-24477v105) | COM SHS | 85,000 | $4 million |
| [Bioage Labs Inc](https://specstream.ai/data/institutional-holders/bioage-labs-inc-09077v100) | COM | 155,000 | $3.8 million |
| [Scynexis Inc](https://specstream.ai/data/institutional-holders/scynexis-inc-811292309) | COM | 756,884 | $3.1 million |
| [Proqr Thrapeutics N V](https://specstream.ai/data/institutional-holders/proqr-thrapeutics-n-v-n71542109) | SHS EURO | 1,511,496 | $2.8 million |
| Disc Medicine Inc | COM (call) | 30,000 | $2.2 million |
| [Rezolute Inc](https://specstream.ai/data/institutional-holders/rezolute-inc-76200l309) | COM NEW | 403,410 | $2.1 million |
| C4 Therapeutics Inc | COM STK (call) | 400,000 | $1.9 million |
| Ultragenyx Pharmaceutical in | COM (call) | 55,000 | $1.8 million |
| [Cue Biopharma Inc](https://specstream.ai/data/institutional-holders/cue-biopharma-inc-22978p205) | COM | 50,000 | $1.6 million |
| [Calcimedica Inc](https://specstream.ai/data/institutional-holders/calcimedica-inc-38942q202) | COM NEW | 1,244,864 | $1.3 million |
| [Quince Therapeutics Inc](https://specstream.ai/data/institutional-holders/quince-therapeutics-inc-22053a305) | COM | 40,375 | $734,421 |
| Nuvectis Pharma Inc | COM (call) | 38,700 | $711,693 |
| [Inmed Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/inmed-pharmaceuticals-inc-457637700) | COM NEW | 325,000 | $503,750 |
| [Neumora Therapeutics Inc.](https://specstream.ai/data/institutional-holders/neumora-therapeutics-inc-640979100) | COM | 100,000 | $170,000 |

## Positions exited in Q2 2026

18 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Kalvista Pharmaceuticals Inc | COM | 985,100 | $19.8 million |
| [Abivax SA](https://specstream.ai/data/institutional-holders/abivax-sa-00370m103) | SPONSORED ADS | 130,000 | $14.5 million |
| [Nektar Therapeutics](https://specstream.ai/data/institutional-holders/nektar-therapeutics-640268306) | COM NEW | 125,000 | $9 million |
| Scynexis Inc | COM NEW | 7,608,695 | $7 million |
| Kalvista Pharmaceuticals Inc | COM (call) | 315,000 | $6.3 million |
| [Eupraxia Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/eupraxia-pharmaceuticals-inc-29842p105) | COM | 680,000 | $4.9 million |
| [GH Research PLC](https://specstream.ai/data/institutional-holders/gh-research-plc-g3855l106) | ORDINARY SHARES | 325,000 | $4.6 million |
| Karyopharm Therapeutics Inc | COM NEW (put) | 750,000 | $4.2 million |
| Ideaya Biosciences Inc | COM (put) | 120,000 | $4 million |
| Ideaya Biosciences Inc | COM (call) | 104,300 | $3.5 million |
| [Alx Oncology Hldgs Inc](https://specstream.ai/data/institutional-holders/alx-oncology-hldgs-inc-00166b105) | COM | 1,460,000 | $2.9 million |
| [Context Therapeutics Inc](https://specstream.ai/data/institutional-holders/context-therapeutics-inc-21077p108) | COM | 1,100,000 | $2.9 million |
| Relay Therapeutics Inc | COM (call) | 150,000 | $1.5 million |
| [Traws Pharma Inc](https://specstream.ai/data/institutional-holders/traws-pharma-inc-68232v884) | COM NEW | 511,714 | $936,437 |
| [Therapeuticsmd Inc](https://specstream.ai/data/institutional-holders/therapeuticsmd-inc-88338n206) | COM NEW | 420,421 | $849,250 |
| [Spruce Biosciences Inc](https://specstream.ai/data/institutional-holders/spruce-biosciences-inc-85209e208) | COM NEW | 12,200 | $797,270 |
| [Werewolf Therapeutics Inc](https://specstream.ai/data/institutional-holders/werewolf-therapeutics-inc-95075a107) | COM | 563,535 | $469,199 |
| [Neuphoria Therapeutics Inc](https://specstream.ai/data/institutional-holders/neuphoria-therapeutics-inc-64136e102) | COM | 76,728 | $312,283 |

## Also on SpecStream

- [Squadron Capital Management LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/2050709/000205070926000027/0002050709-26-000027-index.htm)
- [Squadron Capital Management LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/squadron-capital-management-llc-334296)
- [Largest 13F filers in Illinois](https://specstream.ai/data/institutional-holdings/state/illinois)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Oak Brook, Illinois

- [Employment agencies in Oak Brook, Illinois](https://specstream.ai/data/businesses/employment-agencies/oak-brook-illinois-united-states)
- [Software development companies in Oak Brook, Illinois](https://specstream.ai/data/businesses/software-development-companies/oak-brook-illinois-united-states)
- [Legal services firms in Oak Brook, Illinois](https://specstream.ai/data/businesses/legal-services-firms/oak-brook-illinois-united-states)
- [IT companies in Oak Brook, Illinois](https://specstream.ai/data/businesses/it-companies/oak-brook-illinois-united-states)
- [Financial services firms in Oak Brook, Illinois](https://specstream.ai/data/businesses/financial-services-firms/oak-brook-illinois-united-states)
- [Accounting firms in Oak Brook, Illinois](https://specstream.ai/data/businesses/accounting-firms/oak-brook-illinois-united-states)
